Allergan Breast Implant Lawsuit Attorneys

Why Women Are Suing Allergan

Researchers have linked Allergan’s Biocell textured breast implants to breast implant–associated anaplastic large cell lymphoma (BIA-ALCL), a rare form of non-Hodgkin’s lymphoma. In July 2019, the FDA requested Allergan recall these implants after finding that women with Allergan’s textured implants were six times more likely to develop BIA-ALCL than those with other implants.

Despite the recall, Allergan has not covered removal costs, fueling lawsuits nationwide. Our firm represents women who received Allergan textured implants and were later diagnosed with BIA-ALCL.

Allergan Breast Implant Lawsuit Updates (2024–2025)

• July 2025: 1,456 lawsuits pending in the federal MDL-2921 (District of New Jersey).

• May 2025: 1,431 lawsuits active.

• April 2025: 1,261 lawsuits pending; American Society of Plastic Surgeons reports 456 suspected or confirmed U.S. BIA-ALCL cases.

• Jan–Mar 2025: Monthly case management orders issued; litigation is progressing at a steady pace.

• Aug 2024: Judge Martinotti extended bellwether trial deadlines into 2025.

• Dec 2019: MDL established to consolidate all Allergan Biocell breast implant claims.

Status: The litigation is active. Women with BIA-ALCL linked to Allergan implants may still be eligible to file lawsuits.

What Is BIA-ALCL?

Breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) is not breast cancer—it is a rare T-cell lymphoma that forms in scar tissue surrounding textured implants.

Symptoms of BIA-ALCL

• Persistent swelling or fluid around implant

• Lumps in breast or armpit

• Pain near implant site

• Fatigue, fever, or night sweats

Treatment

When diagnosed early, treatment often involves removing the implant and scar capsule. Advanced cases may require chemotherapy or radiation.

Contact Us Today for a FREE Consultation

If you or a loved one has experienced health complications due to Allergan Breast Implants, don’t wait to seek legal help.

Contact Salenger, Sack, Kimmel & Bavaro today for a FREE consultation.

Call (800) 675-8556 or contact us online to get started. 

Allergan Breast Implant Recall Timeline

• 2016: WHO classifies BIA-ALCL as a lymphoma subtype.

• 2018: Allergan implants pulled from EU, Israel, Brazil, and Australia markets.

• May 2019: Health Canada suspends Allergan Biocell sales.

• July 24, 2019: FDA requests U.S. recall of all Allergan textured implants & tissue expanders.

• 2019: Federal MDL created in New Jersey to centralize lawsuits.

Potential Compensation

Women filing Allergan breast implant lawsuits may pursue damages for:

• • Medical costs for implant removal & treatment
    
  • Pain and suffering (physical & emotional)
    
  • Lost wages and earning capacity
    
  • Funeral expenses (wrongful death claims)
  • Punitive damages (where permitted)

Am I Eligible to File?

You may qualify if you:

• • Received an Allergan Biocell textured breast implant
    
  • Were diagnosed with BIA-ALCL or other complications linked to implants
  • Filed (or can still file) within your state’s statute of limitations

Not sure? Contact our team—we’ll evaluate your case at no cost.

FAQs

What are Allergan Biocell textured breast implants?
They are a type of silicone or saline implant with a rough outer shell designed to prevent shifting. These are the implants most strongly linked to BIA-ALCL.

What is the risk of developing BIA-ALCL?
Estimates range from 1 in 1,000 to 1 in 30,000 women with textured implants.

Can I still file if my implants were removed years ago?
Yes. If you were later diagnosed with BIA-ALCL, you may still qualify.

Free, Confidential Consultation! If you were diagnosed with BIA-ALCL after Allergan implants, call (800) 675-8556 or complete our secure form today.